KBI BioPharma, Inc., is a biopharmaceutical contract services company providing drug development and biomanufacturing services for pharmaceutical and biotechnology companies. The company engages in biophysical and biochemical protein characterization, formulation and process development, and cGMP manufacturing of recombinant protein active pharmaceutical ingredients. It also provides formulation, analytical method development, stability services, and process development services. These services include process development, protein formulation development (including both liquid and lyo). analytical development (including extensive biophysical characterization capabilities), ICH stability, cell line development (including PER.C6) and cGMP manufacturing for both mammalian cell culture and microbial programs. KBI BioPharma spun-out of Kinetic Biosystems Inc., an Atlanta-based developmental stage life sciences company formed in 1997 to commercialize bioreactor technology developed by Dr. Heath Herman, a professor at the Georgia Institute of Technology. Bioreactors are large stainless steel vessels used for growing cells under carefully controlled conditions.
